Endovascular Management of TASC-C and D Aortoiliac Occlusive Disease

• Published in: Current surgery reports (Philadelphia, PA) PA), 2023-01, Vol.11 (1), p.17-22
• Main Authors: Kang, Jeanwan, Kim, Ann H., Zhang, Jackie M.
• Format: Article
• Language: English
• Subjects: Medicine; Medicine & Public Health; Section Editor; Surgery; Vascular Surgery (S Toursavadkohi
• ISSN: 2167-4817; 2167-4817
• DOI: 10.1007/s40137-022-00341-w

Purpose of Review Recent advances in endovascular techniques and device technology have led to increased utilization of endovascular treatment for patients with severe aortoiliac occlusive disease. In this review article, we will discuss various clinical and technical considerations in endovascular treatment of patients with TASC C and D aortoiliac lesions and provide review of the existing literature. Recent Findings While primary patency remains superior following open aortoiliac reconstruction, secondary patency, limb salvage and survival following endovascular management of aortoiliac occlusive disease rival those for open surgical management. In addition, endovascular management offers lower perioperative morbidity and mortality and shorter hospital stay and does not preclude patients from undergoing aortobifemoral bypass in the future should the initial endovascular treatment fail. Covered stent grafts result in improved patency for TASC C and D common iliac artery lesions and concomitant common femoral endarterectomy can be performed with good result in those with disease extending into the common femoral artery. Summary With careful patient selection and operative planning, endovascular intervention for TASC C and D aortoiliac lesions can be performed with excellent results and should be considered as the first line treatment in patients with severe AIOD.